Prognostic role of derived neutrophil-to-lymphocyte ratio in surgical triple-negative breast cancer

Abstract

Pretreatment dNLR is an independent factor of prognosis for TNBC patients, which potentially allows clinical doctors to improve outcomes of patients with high dNLR by treating with aggressive therapy, such as high-dose adjuvant chemotherapy and radiotherapy.